Ixekizumab OverviewIxekizumab (pronounced ix-ee-KIZ-ue-mab) also known under trade name Taltz is an injectable drug for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation. The drug was developed by Eli Lilly and Co. and is approved for the treatment of plaque psoriasis in Europe and the US. Contents ...
Read more Ixekizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ixekizumab
Recent Ixekizumab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 80mg/ml